Result Summary for 115375
| Protocol ID: | 115375 |
| Clinical Study ID: | 115375 |
| Official Title: | Antibody persistence in children previously vaccinated with three doses of Infanrix hexa™ or Infanrix-IPV/Hib™ |
| Phase: | phase 4 |
| Study Indications or Diseases: |
|
| Generic Name: | Combined Diphteria, Tetanus, Acellular Pertussis, Hepatitis B, Inactivated Polio, Haemophilus influenzae Type b Vaccine |
| Trade/Product Name: | Infanrix-Hexa |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
